Yann Mazabraud, EVP, Head of International at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 13,490 shares at $65.08 ($878K) on 2025-04-29, disclosed to the SEC on 2025-05-01.
Scheduled sale ($878k) by EVP, Head of International under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.08 | 6,745 | $439K | 50.0% |
| 2 | $65.08 | 6,745 | $439K | 50.0% |
| Total | $65.08 avg | 13,490 | $878K | 100% |
| Filing → |
| RYTM | SELL | 2025-03-18 | $7.7M | — | Filing → |
| RYTM | SELL | 2024-03-19 | $628K | — | Filing → |
| RYTM | SELL | 2024-02-13 | $211K | — | Filing → |